These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6442003)

  • 1. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of nitrates in acute therapy of heart failure with and without lung edema].
    Beck OA
    Z Kardiol; 1985; 74 Suppl 1():15-22. PubMed ID: 3922141
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
    Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasodilators, oral nitrate derivatives and treatment of heart failure].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(2):139-46. PubMed ID: 825345
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise.
    Wilson JR; Ferraro N
    Am J Med; 1981 Oct; 71(4):627-33. PubMed ID: 7282752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasodilator therapy of congestive heart failure].
    Schröder R
    Dtsch Med Wochenschr; 1977 Sep; 102(39):1388-94. PubMed ID: 410617
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
    Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
    Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nitrates in congestive heart failure.
    Cohn JN
    Am J Cardiol; 1987 Nov; 60(15):39H-43H. PubMed ID: 3120564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasodilators in heart failure secondary to coronary artery disease.
    Parmley WW; Rouleau JL; Chatterjee K
    Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent findings on nitrates: their action, bioactivation and development of tolerance].
    Münzel T
    Dtsch Med Wochenschr; 2008 Oct; 133(44):2277-82. PubMed ID: 18946854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nitrate derivatives and cardiac insufficiency].
    Komajda M; Isnard R; Lechat P
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():29-32. PubMed ID: 1530425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: The effect of nitrates on the systemic circulation and the myocardial oxygen consumption].
    Tauchert M; Behrenbeck DW; Niehues B; Hilger HH
    Z Kardiol; 1975; Suppl 2():84. PubMed ID: 812281
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and hemodynamic evaluation of isosorbide dinitrate therapy in heart failure (author's transl)].
    Miranda V; Saavedra J; Opazo JA; Stockins B; Contreras M; Lanas F
    Rev Med Chil; 1979 Aug; 107(8):721-3. PubMed ID: 545565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.